Dear Friend,

This year Democracy Now! is celebrating our 25th anniversary—that's 25 years of bringing you fearless, independent reporting. Since our very first broadcast in 1996, Democracy Now! has refused to take government or corporate funding, because nothing is more important to us than our editorial independence. But that means we rely on you, our audience, for support. Please donate today in honor of our 25th anniversary and help us stay on air for another 25 years. We can't do our work without you. Right now, a generous donor will even DOUBLE your gift, which means it’ll go twice as far! This is a challenging time for us all, but if you're able to make a donation, please do so today. Thank you and remember, wearing a mask is an act of love.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


Denmark, Norway and Iceland Halt AstraZeneca Vaccinations over Blood Clot Fears

HeadlineMar 12, 2021

The U.S. recorded 62,000 new coronavirus infections and over 1,500 deaths Thursday as governors continue to roll back public health measures.

In Europe, Demark, Norway and Iceland have suspended use of AstraZeneca’s COVID-19 vaccine after reports of severe cases of blood clots — and one death — in vaccinated people. It’s not known if the vaccine caused the clots, and European Union regulators say the vaccine’s benefits continue to outweigh its risks.

Meanwhile, Reuters is reporting that Biden administration officials have denied requests to ship millions of stockpiled doses of AstraZeneca vaccine from Ohio and Maryland to countries desperate to use them — even though the vaccine is not approved for use in the United States.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation